---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-007283"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2024-10-22T23:59:59+00:00"
generated_at: "2026-05-30T11:33:38.044419+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sonoma expands Medline distribution to Canada and OTC retail in US and Canada

## Summary
- Amendment No. 1 to Distribution Agreement with Medline dated Oct 17, 2024 adds Canada and OTC wound care sales to retailers.
- Original 5-year US distribution deal signed Aug 19, 2024; now covers both countries and OTC channel.
- Updated investor presentation (Oct 22, 2024) highlights 20% YoY European revenue growth in Q1 FY2025 and gross margin improvement to 39%.
- New FDA 510(k) clearance received Sep 2024 for OTC face/eyelid/eyelash indications and smaller product size.
- Distribution expanded in Ukraine, South Korea, and EU through new partners in 2024.

## SEC filing metadata
- accession: 0001683168-24-007283
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2024-10-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/0001683168-24-007283-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316824007283/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-007283
- JSON: https://secwatch.observer/filing/0001683168-24-007283.json
- Plain text: https://secwatch.observer/filing/0001683168-24-007283.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.